Cargando…
A dual protease approach for expression and affinity purification of recombinant proteins
We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C prot...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877217/ https://www.ncbi.nlm.nih.gov/pubmed/27105777 http://dx.doi.org/10.1016/j.ab.2016.04.006 |
_version_ | 1782433348967202816 |
---|---|
author | Raran-Kurussi, Sreejith Waugh, David S. |
author_facet | Raran-Kurussi, Sreejith Waugh, David S. |
author_sort | Raran-Kurussi, Sreejith |
collection | PubMed |
description | We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C protease, prior to purification, to yield an N-terminally His(6)-tagged protein. Proteins that are only temporarily rendered soluble by fusing them to MBP are readily identified at this stage because they will precipitate after the MBP tag is removed by 3C protease. The remaining soluble His(6)-tagged protein, if any, is subsequently purified by immobilized metal affinity chromatography (IMAC). Finally, the N-terminal His(6) tag is removed by His(6)-tagged tobacco etch virus (TEV) protease to yield the native recombinant protein, and the His(6)-tagged contaminants are removed by adsorption during a second round of IMAC, leaving only the untagged recombinant protein in the column effluent. The generic strategy described here saves time and effort by removing insoluble aggregates at an early stage in the process while also reducing the tendency of MBP to “stick” to its fusion partners during affinity purification. |
format | Online Article Text |
id | pubmed-4877217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-48772172017-07-01 A dual protease approach for expression and affinity purification of recombinant proteins Raran-Kurussi, Sreejith Waugh, David S. Anal Biochem Article We describe a new method for affinity purification of recombinant proteins using a dual protease protocol. Escherichia coli maltose binding protein (MBP) is employed as an N-terminal tag to increase the yield and solubility of its fusion partners. The MBP moiety is then removed by rhinovirus 3C protease, prior to purification, to yield an N-terminally His(6)-tagged protein. Proteins that are only temporarily rendered soluble by fusing them to MBP are readily identified at this stage because they will precipitate after the MBP tag is removed by 3C protease. The remaining soluble His(6)-tagged protein, if any, is subsequently purified by immobilized metal affinity chromatography (IMAC). Finally, the N-terminal His(6) tag is removed by His(6)-tagged tobacco etch virus (TEV) protease to yield the native recombinant protein, and the His(6)-tagged contaminants are removed by adsorption during a second round of IMAC, leaving only the untagged recombinant protein in the column effluent. The generic strategy described here saves time and effort by removing insoluble aggregates at an early stage in the process while also reducing the tendency of MBP to “stick” to its fusion partners during affinity purification. Elsevier 2016-07-01 2016-04-19 /pmc/articles/PMC4877217/ /pubmed/27105777 http://dx.doi.org/10.1016/j.ab.2016.04.006 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Raran-Kurussi, Sreejith Waugh, David S. A dual protease approach for expression and affinity purification of recombinant proteins |
title | A dual protease approach for expression and affinity purification of recombinant proteins |
title_full | A dual protease approach for expression and affinity purification of recombinant proteins |
title_fullStr | A dual protease approach for expression and affinity purification of recombinant proteins |
title_full_unstemmed | A dual protease approach for expression and affinity purification of recombinant proteins |
title_short | A dual protease approach for expression and affinity purification of recombinant proteins |
title_sort | dual protease approach for expression and affinity purification of recombinant proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877217/ https://www.ncbi.nlm.nih.gov/pubmed/27105777 http://dx.doi.org/10.1016/j.ab.2016.04.006 |
work_keys_str_mv | AT rarankurussisreejith adualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins AT waughdavids adualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins AT rarankurussisreejith dualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins AT waughdavids dualproteaseapproachforexpressionandaffinitypurificationofrecombinantproteins |